MORTALITY AMONG INHABITANTS OF AN HTLV-I ENDEMIC AREA IN JAPAN

被引:19
作者
IWATA, K
ITO, S
SAITO, H
ITO, M
NAGATOMO, M
YAMASAKI, T
YOSHIDA, S
SUTO, H
TAJIMA, K
机构
[1] IZUHARA HOSP,IZUHARA,NAGASAKI 817,JAPAN
[2] NATL NAGASAKI CENT HOSP,KUBAHARA,OMURA 856,JAPAN
[3] YOSHIDA CLIN,IZUHARA,NAGASAKI 817,JAPAN
[4] SUTO CLIN,IZUHARA,NAGASAKI 817,JAPAN
[5] AICHI CANC CTR,RES INST,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1994年 / 85卷 / 03期
关键词
HTLV-I CARRIER; MORTALITY; PROSPECTIVE COHORT STUDY;
D O I
10.1111/j.1349-7006.1994.tb02087.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A community-based cohort study was conducted to clarify the risk of human T-cell leukemia virus type I (HTLV-I) infection for cause-specific deaths. A total of 1,997 individuals (751 men and 1,246 women) aged 30 or older in A-Island, Nagasaki Prefecture, Japan who had voluntarily attended annual mass health examinations, including serum HTLV-I antibody test, were followed up for a mean period of 5.3 years. In a Cox proportional hazards analysis adjusted for age at baseline, the HTLV-1 seropositivity was found to be associated with mortality from all causes in men (hazard ratio (HR) 1.89; 95% confidence interval (CI) 1.01 3.54) and women (HR 1.94; 95% CI 1.16 3.22). When the effects of 2 deaths (1 man and 1 woman) from adult T-cell leukemia/lymphoma (ATL) were excluded, the mortality risk decreased slightly but was still significantly or marginally significantly greater than 1 in both men (HR 1.77; 95% CI 0.93 3.37) and women (HR 1.87; 95% CI 1.12 3.12). Further analysis of cause-specific deaths revealed a significant increase in the risk for non-neoplastic diseases but not for neoplasms excluding ATL. These findings suggest that long-term HTLV-1 infection represents a health hazard greater than just that for the development of ATL. It was difficult, however, to draw a conclusion regarding the association between HTLV-1 infection and cancer risk, because the number of cancer deaths was small and the incidence of cancer was not investigated.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 37 条
[1]  
ASOU N, 1986, CANCER, V58, P903, DOI 10.1002/1097-0142(19860815)58:4<903::AID-CNCR2820580417>3.0.CO
[2]  
2-J
[3]   EPIDEMIOLOGY OF HTLV-I IN GABON (WESTERN EQUATORIAL AFRICA) [J].
DELAPORTE, E ;
DUPONT, A ;
PEETERS, M ;
JOSSE, R ;
MERLIN, M ;
SCHRIJVERS, D ;
HAMONO, B ;
BEDJABAGA, L ;
CHERINGOU, H ;
BOYER, F ;
BRUNVEZINET, F ;
LAROUZE, B .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :687-689
[4]   IMPROVEMENT OF GELATIN PARTICLE AGGLUTINATION-TEST FOR DETECTION OF ANTI-HTLV-I ANTIBODY [J].
FUJINO, R ;
KAWATO, K ;
IKEDA, M ;
MIYAKOSHI, H ;
MIZUKOSHI, M ;
IMAI, J .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (04) :367-370
[5]  
GESSAIN A, 1985, LANCET, V2, P407
[6]  
Harrell F., 1983, SUGI SUPPLEMENTAL LI, P267
[7]   ANTIBODIES TO ADULT T-CELL LEUKEMIA-VIRUS-ASSOCIATED ANTIGEN (ATLA) IN SERA FROM PATIENTS WITH ATL AND CONTROLS IN JAPAN - A NATION-WIDE SERO-EPIDEMIOLOGIC STUDY [J].
HINUMA, Y ;
KOMODA, H ;
CHOSA, T ;
KONDO, T ;
KOHAKURA, M ;
TAKENAKA, T ;
KIKUCHI, M ;
ICHIMARU, M ;
YUNOKI, K ;
SATO, I ;
MATSUO, R ;
TAKIUCHI, Y ;
UCHINO, H ;
HANAOKA, M .
INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (06) :631-635
[8]   ADULT T-CELL LEUKEMIA - ANTIGEN IN AN ATL CELL-LINE AND DETECTION OF ANTIBODIES TO THE ANTIGEN IN HUMAN-SERA [J].
HINUMA, Y ;
NAGATA, K ;
HANAOKA, M ;
NAKAI, M ;
MATSUMOTO, T ;
KINOSHITA, KI ;
SHIRAKAWA, S ;
MIYOSHI, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6476-6480
[9]  
IKEDA M, 1984, GANN, V75, P845
[10]  
KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096